Novartis Expects Further Profit, Sales Growth Despite Competition Threat
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart ...
Novartis beats Q4 earnings consensus as drug sales surge
Novartis on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug ...
Novartis Expects Further Profit, Sales Growth Despite Competition Threat — 2nd Update
Novartis said Friday that it expects core operating profit--one of its preferred metrics, which strips out exceptional items--for 2025 to grow in the high-single-digit to low-double-digit range and ...
Novartis AG: Balancing Strong Performance with Future Challenges – Hold Rating Maintained
In a report released today, Eric Le Berrigaud from Stifel Nicolaus maintained a Hold rating on Novartis AG (NOVN – Research Report), with a ...
Thalassemia Market Research by Treatment Type, Type, Distribution Channel, and Region - Global Forecasts 2034-2034
Global Thalassemia Market Global Thalassemia Market Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Thalassemia Market by ...
News Highlights: Top Company News of the Day - Friday at 5 AM ET
The pharma major beat analysts' expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto. The watchdog blocked access to DeepSeek after the companies ...
Procurement Software Market Valuation is Poised to Surpass US$ 17.87 Billion by 2033 | Astute Analytica
Procurement software demand is driven by digital transformation, AI, and sustainability, with key players like SAP Ariba and Coupa leading the market. As businesses prioritize ESG goals, procurement ...